Assessing cancer pain using machine learning and telemedicine
Official title: Home-Based Telemedicine for Automatic Pain Assessment in Cancer Patients: Dataset Creation and Development of Machine Learning Algorithms
Run by National Cancer Institute, Naples · NCT04726228 · Data updated 2026-11-12
This study is testing a new way to help cancer patients manage their pain better by using technology and support from healthcare teams while they stay at home.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | National Cancer Institute, Naples Academic / other |
| Locations | 2 sites (Naples, Campania and 1 other locations) |
| Status | Recruiting |
| Started | June 21, 2021 |
| Main results expected | February 23, 2022 |
| Study ends | October 2025 |
| Registry record updated | July 29, 2025 |
| Trial ID | NCT04726228 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with advanced cancer and a life expectancy of one year or less who are receiving treatment for cancer pain.
✕Probably not a fit
Patients under 18 years old or those with cognitive deficits may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on improving pain management in cancer patients through the integration of telemedicine and machine learning. Patients diagnosed with advanced cancer will be monitored at home by the Early Palliative Care team, utilizing various clinical assessment tools and a mobile application for data collection. The study aims to develop algorithms for automatic pain recognition, enhancing the quality of life and treatment adherence for patients experiencing cancer pain. The project is structured into three work packages, including IT infrastructure development, patient data collection, and algorithm development.
Why it matters
Potential benefit: If successful, this approach could significantly enhance pain management and quality of life for cancer patients.
How similar studies have gone: Other studies have shown promise in using telemedicine and machine learning for pain assessment, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged \> 18 years * Home care patients diagnosed with advanced cancer disease and life expectancy ≤ 1 year * Patients receiving treatment for cancer pain * Patients who have given their consent Exclusion Criteria: * Patients aged \< 18 years * Willingness to sign the informed consent form (unable to read or write) * Cognitive deficit (e.g. Alzheimer disease or senile dementia)
Where it's running
-
National Cancer Institute of Naples
Naples, Campania, Italy Recruiting -
A.O.U. Federico II
Naples, Campania, Italy Not yet recruiting
Study contacts
- Principal investigator: Marco Cascella, MD — Anesthesia and Pain Medicine. Istituto Nazionale Tumori - IRCCS Fondazione Pascale - Napoli, Italy
- Study coordinator: Marco Cascella, MD
- Email: m.cascella@istitutotumori.na.it
- Phone: +39 0815903508
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Triple-target radiosurgery for cancer pain using pituitary and thalamic neuromodulation
This study tests whether focused brain radiosurgery to the pituitary and specific thalamic regions can reduce pain in adults with cancer that’s not controlled by opioids or other treatments.
-
Hydromorphone plus electroacupuncture and ear acupressure for refractory cancer pain
This trial tests whether adding electroacupuncture and ear acupressure to hydromorphone extended-release tablets helps relieve refractory cancer pain.
-
Tibetree topical herbal plasters for people using opioids for cancer pain
This trial will try Tibetree topical herbal plasters together with prescribed opioids to see if they reduce localized cancer-related pain for adults who are currently taking short-term oral opioids.
-
Transdiscal versus paravertebral splanchnic nerve neurolysis for upper abdominal cancer pain
This will test whether the transdiscal or the paravertebral splanchnic nerve neurolysis gives better pain relief for people with severe upper abdominal cancer pain that hasn't responded to medicines.
-
MRI-guided focused ultrasound mesencephalotomy for opioid-resistant head, neck, and brachial cancer pain
This study will try MRI-guided focused ultrasound to make a tiny, precise lesion in the midbrain to relieve severe, opioid-resistant head, neck, or brachial cancer pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.